List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 1290 studies with search of: squamous cell carcinoma
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy
Conditions: Adenocarcinoma;   Squamous Cell Carcinoma;   Relevant Condition Terms to the Conditions Field
Intervention: Radiation: CT, radiation therapy
2 Active, not recruiting Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma
Condition: Squamous Cell Carcinoma
Intervention: Drug: Tarceva, Torisel
3 Completed Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma;   Carcinoma of Head/Neck
Interventions: Drug: Taxotere;   Drug: Cisplatin;   Drug: 5-Fluorouracil;   Drug: Leucovorin;   Drug: G-CSF;   Drug: Ciprofloxacin
4 Recruiting Efficacy Comparison Study of Combination Regimens to Treat Advanced Esophageal Squamous Cell Carcinoma
Conditions: First Line Chemotherapy;   Capecitabine Plus Cisplatin Versus Capecitabine Plus Paclitaxel;   Advanced or Recurrent Esophageal Squamous Cell Carcinoma
Intervention: Drug: Capecitabine plus cisplatin(XP) versus capecitabine plus paclitaxel(XT)
5 Active, not recruiting Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: Tarceva;   Drug: Tarceva plus sulindac;   Drug: Placebo
6 Recruiting A Study of PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
Intervention: Drug: PF-00299804
7 Recruiting Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma
Condition: Local Advanced Esophageal Squamous Cell Carcinoma
Interventions: Drug: Placebo, Radiotherapy and Chemotherapy;   Drug: Nimotuzumab, Radiotherapy and Chemotherapy
8 Not yet recruiting Prognostic Factor Analysis in Metastatic Esophageal Squamous Cell Carcinoma
Condition: Metastatic Esophageal Squamous Cell Carcinoma
Intervention:
9 Recruiting Phase II Trial of XP Versus XG in Advanced Esophageal Squamous Cell Carcinoma
Condition: Advanced or Recurrent Esophageal Squamous Cell Carcinoma
Interventions: Drug: Capecitabine/Cisplatin(XP);   Drug: Capecitabine/Paditaxel(XG)
10 Active, not recruiting Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar
Condition: Squamous Cell Carcinoma
Intervention: Drug: Erlotinib
11 Recruiting Comparison of Elective Lymph Node Treatment Versus Clinical Observation in the Absence of Palpable Lymph Nodes for High Risk Skin Squamous Cell Carcinoma (SCC)
Condition: High Risk Cutaneous Squamous Cell Carcinoma
Intervention: Procedure: elective lymph node dissection
12 Recruiting Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer
Conditions: Skin Cancer;   Basal Cell Carcinoma;   Squamous Cell Carcinoma
Intervention:
13 Completed Dasatinib in Patients With Head and Neck Squamous Cell Carcinoma
Conditions: Head and Neck Cancer;   Squamous Cell Carcinoma
Intervention: Drug: Dasatinib
14 Completed Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Conditions: Advanced Squamous Cell Carcinoma;   Squamous Cell Carcinoma of Head and Neck;   SSCHN
Interventions: Drug: Docetaxel;   Drug: Cisplatin;   Drug: 5-Fluorouracil
15 Unknown † Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC
Conditions: Squamous Cell Carcinoma;   Non-small Cell Lung Cancer
Intervention: Drug: Erlotinib + Rosuvastatin
16 Active, not recruiting Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
Intervention: Biological: the arachidonic acid and EGFR signaling pathways and their interaction in HNSCC tumorigenesis,
17 Recruiting Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: Chemotherapy;   Drug: Nimotuzumab and Chemotherapy
18 Completed Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma;   Carcinoma of Head and/or Neck
Interventions: Drug: Taxotere;   Drug: Cisplatin;   Drug: 5-Fluorouracil;   Drug: Leucovorin
19 Active, not recruiting A Trial Exploring the Efficacy of EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)
Condition: Squamous Cell Carcinoma of the Head and Neck Cancer
Interventions: Drug: Cetuximab in combination with EMD 1201081;   Drug: Cetuximab alone
20 Terminated Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Condition: Squamous Cell Carcinoma
Interventions: Drug: Azacitidine;   Drug: Cisplatin

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services